Cargando…

Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening

Background: The role of sodium bicarbonate therapy (SBT) remains controversial. This study aimed to investigate whether hemodynamic status before SBT contributed to the heterogeneous outcomes associated with SBT in acute critically ill patients. Methods: We obtained data from patients with metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tiehua, Yi, Lingxian, Zhang, Hua, Wang, Tianhao, Xi, Jingjing, Zeng, Lin, He, Junlin, Zhang, Zhongheng, Ma, Penglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292723/
https://www.ncbi.nlm.nih.gov/pubmed/34307402
http://dx.doi.org/10.3389/fmed.2021.665907
_version_ 1783724883239239680
author Wang, Tiehua
Yi, Lingxian
Zhang, Hua
Wang, Tianhao
Xi, Jingjing
Zeng, Lin
He, Junlin
Zhang, Zhongheng
Ma, Penglin
author_facet Wang, Tiehua
Yi, Lingxian
Zhang, Hua
Wang, Tianhao
Xi, Jingjing
Zeng, Lin
He, Junlin
Zhang, Zhongheng
Ma, Penglin
author_sort Wang, Tiehua
collection PubMed
description Background: The role of sodium bicarbonate therapy (SBT) remains controversial. This study aimed to investigate whether hemodynamic status before SBT contributed to the heterogeneous outcomes associated with SBT in acute critically ill patients. Methods: We obtained data from patients with metabolic acidosis from the Medical Information Mart for Intensive Care (MIMIC)-III database. Propensity score matching (PSM) was applied to match the SBT group with the control group. Logistic regression and Cox regression were used to analyze a composite of newly “developed or exacerbated organ dysfunction” (d/eOD) within 7 days of ICU admission and 28-day mortality associated with SBT for metabolic acidosis. Results: A total of 1,765 patients with metabolic acidosis were enrolled, and 332 pairs obtained by PSM were applied to the final analyses in the study. An increased incidence of newly d/eOD was observed in the SB group compared with the control group (54.8 vs. 44.6%, p < 0.01). Multivariable logistic regression indicated that the adjusted OR of SBT for this composite outcome was no longer significant [OR (95% CI): 1.39 (0.9, 1.85); p = 0.164]. This effect of SBT did not change with the quintiles stratified by pH. Interestingly, SBT was associated with an increased risk of the composite of newly d/eOD in the subgroup of patients with worsening hemodynamics before SBT [adjusted OR (95% CI): 3.6 (1.84, 7.22), p < 0.001]. Moreover, the risk potential for this composite of outcomes was significantly increased in patients characterized by both worsening [adjusted OR (95% CI): 2.91 (1.54, 5.47), p < 0.001] and unchanged hemodynamics [adjusted OR (95% CI): 1.94 (1.01, 3.72), p = 0.046] compared to patients with improved hemodynamics before SBT. Our study failed to demonstrate an association between SBT and 28-day mortality in acute critically ill patients with metabolic acidosis. Conclusions: Our findings did not demonstrate an association between SBT and outcomes in critically ill patients with metabolic acidosis. However, patients with either worsening or unchanged hemodynamic status in initial resuscitation had a significantly higher risk potential of newly d/eOD subsequent to SBT.
format Online
Article
Text
id pubmed-8292723
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82927232021-07-22 Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening Wang, Tiehua Yi, Lingxian Zhang, Hua Wang, Tianhao Xi, Jingjing Zeng, Lin He, Junlin Zhang, Zhongheng Ma, Penglin Front Med (Lausanne) Medicine Background: The role of sodium bicarbonate therapy (SBT) remains controversial. This study aimed to investigate whether hemodynamic status before SBT contributed to the heterogeneous outcomes associated with SBT in acute critically ill patients. Methods: We obtained data from patients with metabolic acidosis from the Medical Information Mart for Intensive Care (MIMIC)-III database. Propensity score matching (PSM) was applied to match the SBT group with the control group. Logistic regression and Cox regression were used to analyze a composite of newly “developed or exacerbated organ dysfunction” (d/eOD) within 7 days of ICU admission and 28-day mortality associated with SBT for metabolic acidosis. Results: A total of 1,765 patients with metabolic acidosis were enrolled, and 332 pairs obtained by PSM were applied to the final analyses in the study. An increased incidence of newly d/eOD was observed in the SB group compared with the control group (54.8 vs. 44.6%, p < 0.01). Multivariable logistic regression indicated that the adjusted OR of SBT for this composite outcome was no longer significant [OR (95% CI): 1.39 (0.9, 1.85); p = 0.164]. This effect of SBT did not change with the quintiles stratified by pH. Interestingly, SBT was associated with an increased risk of the composite of newly d/eOD in the subgroup of patients with worsening hemodynamics before SBT [adjusted OR (95% CI): 3.6 (1.84, 7.22), p < 0.001]. Moreover, the risk potential for this composite of outcomes was significantly increased in patients characterized by both worsening [adjusted OR (95% CI): 2.91 (1.54, 5.47), p < 0.001] and unchanged hemodynamics [adjusted OR (95% CI): 1.94 (1.01, 3.72), p = 0.046] compared to patients with improved hemodynamics before SBT. Our study failed to demonstrate an association between SBT and 28-day mortality in acute critically ill patients with metabolic acidosis. Conclusions: Our findings did not demonstrate an association between SBT and outcomes in critically ill patients with metabolic acidosis. However, patients with either worsening or unchanged hemodynamic status in initial resuscitation had a significantly higher risk potential of newly d/eOD subsequent to SBT. Frontiers Media S.A. 2021-07-07 /pmc/articles/PMC8292723/ /pubmed/34307402 http://dx.doi.org/10.3389/fmed.2021.665907 Text en Copyright © 2021 Wang, Yi, Zhang, Wang, Xi, Zeng, He, Zhang and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Tiehua
Yi, Lingxian
Zhang, Hua
Wang, Tianhao
Xi, Jingjing
Zeng, Lin
He, Junlin
Zhang, Zhongheng
Ma, Penglin
Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening
title Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening
title_full Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening
title_fullStr Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening
title_full_unstemmed Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening
title_short Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy in Critically Ill Patients With Hemodynamic Worsening
title_sort risk potential for organ dysfunction associated with sodium bicarbonate therapy in critically ill patients with hemodynamic worsening
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292723/
https://www.ncbi.nlm.nih.gov/pubmed/34307402
http://dx.doi.org/10.3389/fmed.2021.665907
work_keys_str_mv AT wangtiehua riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT yilingxian riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT zhanghua riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT wangtianhao riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT xijingjing riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT zenglin riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT hejunlin riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT zhangzhongheng riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening
AT mapenglin riskpotentialfororgandysfunctionassociatedwithsodiumbicarbonatetherapyincriticallyillpatientswithhemodynamicworsening